LuciRibo

药品简介

Originator: KISQALI by NOVARTIS · Manufacturer: Lucius Pharma. Indication & Dosage: LuciRibo (Ribociclib), generic KISQALI is a prescription medicine used to treat patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. Ribociclib is in a class of medicine called kinase inhibitors. Ribociclib works by blocking the action of an abnormal protein that signals cancer cells to multiply. Ribociclib helps slow or stop the spread of Cancer cells. LuciRibo is manufactured by Lucius Pharma Ltd. In Laos. Ribociclib has to take orally once daily for 21 days with Or Without food, then stopping the medicine for 7 days. Side Effects: The most common side effects of Ribociclib are: Tiredness , diarrhea , headache , back pain, nausea , vomiting , or loss of appetite. The above information comes from the Internet. Please consult with doctor for medical advice.

本信息仅供参考，不构成医疗建议。请务必咨询合格的医疗专业人士。